Japan's Takeda applies for gov't approval of Moderna's booster shots

Japan's Takeda Pharmaceutical Co. has applied with the health ministry for approval to use the COVID-19 vaccine developed by U.S. biotechnology firm Moderna Inc. for booster shots from February, company officials said Thursday.Takeda, which is in charge of sales and distribution of the Moderna vaccine in Japan, submitted the application on Wednesday seeking the green light for the amount to be used and the method in administering it. Clinical trial data were also presented.A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at t…READ FULL ARTICLE